CUSTOMER SUPPORT
Need help? Have a question or a suggestion?
Statin Induced Myopathy
While generally a safe and effective means of lowering LDL cholesterol levels, the side-effects of statins may include a muscle related condition known as statin-induced myopathy. deCODEme identifies a genetic variant associated with increased risk of developing myopathy when taking statin drugs.
Your result:
Very low (0.3%) chance of myopathy in the first year of taking a high dose of statins
Based on the deCODEme Genetic test for the genetic variant (rs4149056) associated with statin induced myopathy, your results are: (highlighted in green)
| rs4149056 | ||||
|---|---|---|---|---|
| Very low (0.3%) chance of myopathy in the first year of taking a high dose of statins* |
 YOU > |
TT | ||
| Low (1.4%) chance of myopathy in the first year of taking a high dose of statins* |
|
|||
| Moderate (15%) chance of myopathy in the first year of taking a high dose of statins* |
|
|||
- * A high dose of statins is defined here as a daily dose of 80 mg of Simvastatin. The reported risk of developing myopathy may also apply to other types of statins.
Keep in mind
These are the results of calculations comparing your genetic sequence to sequence of participants in studies published in the world literature.
Regardless of the outcome of the deCODEme Genetic Scan, if you have the described signs and symptoms of statin induced myopathy, you should talk to your doctor since the symptoms could be due to other genetic variants or an indication of another illness.